5-chloro-4-methyl-N-(pyridin-3-ylmethyl)-1,3-benzothiazol-2-amine, 95.0%, 500mg

METHYL 5-BROMO-4-NITRO-1H-INDAZOLE-3-CARBOXYLATE, 95.0%, 10g

(S)-2-(BOC-AMINO)-2-VINYL-ETHANOL, 97.0%, 5g

Tashiro indicator solution, in ethanol, 250 ml, plastic packaging.

(2S,4R)-Methyl 4-hydroxy-1-(3-methyl-2-(3-methylisoxazol-5-yl)butanoyl)pyrrolidine-2-carboxylate, 98%, 1g

(6-Methoxybenzo[b]thiophen-2-yl)boronic acid, 97%, 1g

2-Amino-N,N-dimethylpropanamide hydrochloride, 95%, 1g

N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3,4-bis((tert-butyldimethylsilyl)oxy)tetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide, 95%, 2g

Tri-p-tolylphosphine oxide, 95.0%, 5g

Analytical and precision scale Entris® II series Models with internal adjustment, not certified, 0.0001 g, 120 g, BCE124i-1S (W)

Sodium chloride min. 99.8%, extra fine, with anti-caking agent, 1 kg, plastic packaging.

4-Cyclopropyl-1,3-thiazole-5-carboxylic acid, 95%, 500mg

GC capillary column ROTI®Cap-1, 25 m, 0.53 mm, 0.50 µm, 1 Piece(s)